Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
With
American Heart Association
Weizmann Institute of Science
Age
18–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy overweight or obese prediabetic (HbA1c \<8.0%)
BMI ≥27 kg/m2
Oral medications with metformin, sulfonylureas, DPP4 inhibitors
Posses smartphone or use study loaner smartphone
You may not be if
unable or unwilling to provide informed consent
unable to participate meaningfully in an intervention that involves self-monitoring using software available in English (e.g., due to uncorrected sight impairment, illiterate, non-English-speaking, dementia)
unwilling to accept randomization assignment
women who pregnant, or plan to become pregnant in the next 13 months, or who become pregnant during the study
institutionalized (e.g., in a nursing home or personal care facility, or those who are incarcerated and have limited control over diet)
unwilling to delay bariatric surgery for the next 12 months
diagnosed with heart disease, kidney disease, or retinopathy, (to rule-out those with long-standing T2D)
chronically active inflammatory or neoplastic disease in the past 3 years
diagnosed with a chronic gastrointestinal disorder (e.g. inflammatory bowel disease or celiac disease)
diagnosed with active infection requiring antibiotics in the last 3 months or who develop an active infection requiring antibiotics during the study
taking medications containing acetaminophen and are unwilling or unable to discontinue its use during the study (acetaminophen affects the accuracy of the continuous glucose monitoring \[CGM\] device)
taking chronic immunosuppressive medications or used them in the 3 months prior to participation, or during the study
prescribed medications expected to result in weight loss such as Orlistat, Naltrexone, Bupropion, Lorcaserin, Phentermine, Topiramate, or Liraglutide, and who are unwilling to delay treatment with these medications for the next 12 months
+/- 5% weight change within last month at screening
a eGFR \<60 mL/min/1.73m2
younger than 18 or older than 80 years old.
Clareo Health | A Personalized Diet Study to Reduce Glycemic Exposure
